BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38676749)

  • 1. Expression of regional brain amyloid-β deposition with
    Bao YW; Wang ZJ; Guo LL; Bai GJ; Feng Y; Zhao GD
    Neuroradiology; 2024 Apr; ():. PubMed ID: 38676749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centiloid scaling for quantification of brain amyloid with [
    Battle MR; Pillay LC; Lowe VJ; Knopman D; Kemp B; Rowe CC; Doré V; Villemagne VL; Buckley CJ
    EJNMMI Res; 2018 Dec; 8(1):107. PubMed ID: 30519791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Evaluation of
    Matsuda H; Ito K; Ishii K; Shimosegawa E; Okazawa H; Mishina M; Mizumura S; Ishii K; Okita K; Shigemoto Y; Kato T; Takenaka A; Kaida H; Hanaoka K; Matsunaga K; Hatazawa J; Ikawa M; Tsujikawa T; Morooka M; Ishibashi K; Kameyama M; Yamao T; Miwa K; Ogawa M; Sato N
    Front Neurol; 2020; 11():578753. PubMed ID: 33519667
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
    Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
    J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual assessment of [
    Collij LE; Salvadó G; Shekari M; Lopes Alves I; Reimand J; Wink AM; Zwan M; Niñerola-Baizán A; Perissinotti A; Scheltens P; Ikonomovic MD; Smith APL; Farrar G; Molinuevo JL; Barkhof F; Buckley CJ; van Berckel BNM; Gispert JD; ;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2169-2182. PubMed ID: 33615397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Software development for quantitative analysis of brain amyloid PET.
    Matsuda H; Yamao T
    Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Software compatibility analysis for quantitative measures of [
    Pemberton HG; Buckley C; Battle M; Bollack A; Patel V; Tomova P; Cooke D; Balhorn W; Hegedorn K; Lilja J; Brand C; Farrar G
    EJNMMI Res; 2023 May; 13(1):48. PubMed ID: 37225974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [
    Hanseeuw BJ; Malotaux V; Dricot L; Quenon L; Sznajer Y; Cerman J; Woodard JL; Buckley C; Farrar G; Ivanoiu A; Lhommel R
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):302-310. PubMed ID: 32601802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of amyloid load using
    Bullich S; Roé-Vellvé N; Marquié M; Landau SM; Barthel H; Villemagne VL; Sanabria Á; Tartari JP; Sotolongo-Grau O; Doré V; Koglin N; Müller A; Perrotin A; Jovalekic A; De Santi S; Tárraga L; Stephens AW; Rowe CC; Sabri O; Seibyl JP; Boada M
    Alzheimers Res Ther; 2021 Mar; 13(1):67. PubMed ID: 33773598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
    Young P; Heeman F; Axelsson J; Collij LE; Hitzel A; Sanaat A; Niñerola-Baizan A; Perissinotti A; Lubberink M; Frisoni GB; Zaidi H; Barkhof F; Farrar G; Baker S; Gispert JD; Garibotto V; Rieckmann A; Schöll M;
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):734-748. PubMed ID: 37897616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease.
    Hatashita S; Wakebe D; Kikuchi Y; Ichijo A
    Front Aging Neurosci; 2019; 11():251. PubMed ID: 31572167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A universal neocortical mask for Centiloid quantification.
    Bourgeat P; Doré V; Rowe CC; Benzinger T; Tosun D; Goyal MS; LaMontagne P; Jin L; Weiner MW; Masters CL; Fripp J; Villemagne VL; ;
    Alzheimers Dement (Amst); 2023; 15(3):e12457. PubMed ID: 37492802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of semi-quantitative measures of
    Müller EG; Stokke C; Stokmo HL; Edwin TH; Knapskog AB; Revheim ME
    Quant Imaging Med Surg; 2022 Jan; 12(1):493-509. PubMed ID: 34993096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies.
    Bollack A; Markiewicz PJ; Wink AM; Prosser L; Lilja J; Bourgeat P; Schott JM; Coath W; Collij LE; Pemberton HG; Farrar G; Barkhof F; Cash DM;
    Neuroimage; 2023 Oct; 280():120313. PubMed ID: 37595816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET.
    Kim SJ; Ham H; Park YH; Choe YS; Kim YJ; Jang H; Na DL; Kim HJ; Moon SH; Seo SW
    Alzheimers Res Ther; 2022 Oct; 14(1):157. PubMed ID: 36266688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of amyloid distribution by [
    Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
    Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.
    Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O
    JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.